GNOM News and Press, Global X Genomics & Biotechnology ETF From 10/19/23

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...

2023-10-18 21:49:00 ET Summary After many years of Cumberland’s US Equity ETF portfolios being overweight in the healthcare sector, we are now at our lowest relative market weight for a long time. The economic benefits to the sector from the Covid pandemic are over. The...

2023-10-10 07:16:00 ET Summary European countries have been plagued by a persistent medicine shortage for the past few years. Supply chain disruptions and increased demand are driving the shortfall. There are potential solutions; and one could involve breeding a whole lot more...

2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...

2023-09-28 11:15:57 ET Summary The ARK Genomic Revolution ETF is a $2bn actively managed ETF that focuses on companies leveraging genomics in their products and services. Genomic-based applications have the potential to revolutionize healthcare and address modern-day illnesses. ...

2023-09-22 03:30:00 ET Summary Healthcare stocks often serve as powerful painkillers during market declines. While the MSCI World Index fell by 18.1% in 2022, healthcare stocks fell by only 5.4%. Investing effectively in healthcare stocks requires a unique set of skills. ...

2023-08-16 02:28:00 ET Summary Risk-on sentiment and end of pandemic boom have weighed on healthcare. Health insurers and medical device firms have held up better. Growing opportunity in obesity treatments. Tarik Aeta, Global Healthcare Analyst with TD Asset Mana...

2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...

2023-08-11 01:45:00 ET Summary The U.S. healthcare system remains a global outlier in both innovation and cost. The U.S. spends twice as much per capita on healthcare versus its developed-country peers yet life expectancy is lower by 6.3 years. Healthcare companies continue to...

2023-07-25 04:17:00 ET Summary Over the last seven recessionary periods in the U.S., healthcare outperformed the broader market by an average of 10%. Slowing economies call for the resilience that healthcare companies can offer, yet the sector remains at a 10% discount to global e...